Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 5, 1997, Pages 530-534

  Fife, Rose S ^a   Rougraff, Bruce T ^b   Proctor, Carmen ^b   Sledge Jr , George W ^b  

^a INDIANA UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031281806     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90130-X     Document Type: Article

References (21)

1. Silverberg E, Boring CC, Squires TS. Cancer statistics 1990. CA Cancer J Clin 1990;40:9-25.
2. Simon MA. Causes of increased survival of patients with osteosarcoma: current controversies. J Bone Joint Surg Am 1984;66:306-10.
3. Dickson RB. Regulation of tumor-host interactions in breast cancer. J Steroid Biochem Mol Biol 1992;41:389-400.
4. Liotta LA. Tumor invasion and metastases. Cancer Res 1986; 46:1-7.
5. Liotta LA, Stetler-Stevenson WG, Steeg PS. Cancer invasion and metastasis. Cancer Invest 1991;9:543-51.
6. Starkey JR. Cell-matrix interactions during tumor invasion. Cancer Metastasis Rev 1990;9:113-23.
7. Moscatelli D, Rifkin DB. Membrane and matrix localization of proteinases. Biochim Biophys Acta 1988;948:67-85.
8. Ramamurthy NS, Vernillo AT, Lee HM, Golub LM, Rifkin BR. The effect of TCNs on collagenase activity in UMR 106-01 rat osteoblastic osteosarcoma cells. Res Commun Chem Pathol Pharmacol 1990;70:323-35.
9. Tamargo RJ, Bok RA, Brem H. Angiogenesis inhibition by minocycline. Cancer Res 1991;51:672-5.
10. Yu L, Smith G, Brandt K, Myers S, O'Connor B, Brandt D. Reduction of severity of canine OA by prophylactic treatment with oral doxycycline. Arthritis Rheum 1992;35:1150-9.
11. Zucker S, Lysik RM, Ramamurthy NS, Golub LM, Wieman JM, Wilkie DP. Diversity of melanoma membrane proteinases. J Natl Cancer Inst 1985;75:517-25.
12. Birkedal-Hansen H, Taylor RE. Detergent-activation of latent collagenase and resolution of its component molecules. Biochem Biophys Res Commun 1982;107:1173-8.
13. Davies B, Miles DW, Happerfield LC, et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993;67:1126-31.
14. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227: 680-5.
15. Armstrong D, Kauffman S, Ottaviano Y, et al. EGF-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res 1994;54:5280-3.
16. Armstrong D, Isaacs J, Ottaviano Y, Davidson N. Programmed cell death in an estrogen-independent breast cancer cell line, MDA-MB-435. Cancer Res 1992;52:3418-24.
17. Fife RS, Sledge GW. Effects of doxycycline on in vitro growth, migration, and gelatinase activity of breast carcinoma cells. J Lab Clin Med 1995;125:407-11.
18. Dayer J-M, Russell R, Krane S. Collagenase production by rheumatoid synovial cells. Science 1977;195:181-3.
19. Golub L, Ciancio S, Ramamurthy N, Leung M, McNamara TF. Low-dose doxycycline therapy. J Periodontal Res 1990; 25:321-30.
20. Ramamurthy N, Zebrowski E, Golub L. The effect of alloxan diabetes on gingival collagen metabolism in the rat. Arch Oral Biol 1972;17:1551-60.
21. Van den Bogert C, Dontje BHJ, Holtrop M, et al. Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis. Cancer Res 1986;46:3283-9.